| dc.contributor.author |
Gwee, A. |
en_US |
| dc.contributor.author |
Rodrigo, R. |
en_US |
| dc.contributor.author |
Casalaz, D. |
en_US |
| dc.contributor.author |
Ritz, N. |
en_US |
| dc.contributor.author |
Curtis, N. |
en_US |
| dc.date.accessioned |
2014-10-29T09:40:37Z |
en_US |
| dc.date.available |
2014-10-29T09:40:37Z |
en_US |
| dc.date.issued |
2013 |
en_US |
| dc.identifier.citation |
The Medical Journal Australia. 2013; 199(5): 324-6 |
en_US |
| dc.identifier.issn |
0025-729X (Print) |
en_US |
| dc.identifier.issn |
1326-5377 (Electronic) |
en_US |
| dc.identifier.uri |
http://repository.kln.ac.lk/handle/123456789/2241 |
en_US |
| dc.description |
Indexed in MEDLINE;
Comment in: [Gwee A et al, Med J Aust. 2014 ;200(3):149-50.]; Beard FH, Med J Aust. 2014; 200(3):149] |
en_US |
| dc.description.abstract |
Comment on effectiveness of BCG vaccine as a preventive therapy in reducing risk of young children travelling to countries with a high prevalence of TB. |
en_US |
| dc.publisher |
Australasian Medical Publishing Co |
en_US |
| dc.title |
Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG? |
en_US |
| dc.type |
Letter |
en_US |
| dc.identifier.department |
Paediatrics |
en_US |
| dc.creator.corporateauthor |
Australian Medical Association |
en_US |
| dc.creator.corporateauthor |
British Medical Association |
en_US |